Avalo Therapeutics Inc. (AVTX)
NASDAQ · Healthcare
Avalo Therapeutics Inc. Gross Profit 2015–2025
Avalo Therapeutics Inc. annual/quarterly gross profit history and growth rate from 2015 to 2024. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Avalo Therapeutics Inc. gross profit for the quarter ending September 30, 2024 was 963000, a 8854.55% decrease year-over-year.
- Avalo Therapeutics Inc. gross profit for the twelve months ending September 30, 2024 was 689000, a 94.99% decrease year-over-year.
- Avalo Therapeutics Inc. annual gross profit for 2023 was 640000, a 95.62% decrease from 2022.
- Avalo Therapeutics Inc. annual gross profit for 2022 was 14.6 M, a 274.12% increase from 2021.
- Avalo Therapeutics Inc. annual gross profit for 2021 was 3.9 M, a 38.94% decrease from 2020.
- Avalo Therapeutics Inc. annual gross profit for 2020 was 6.4 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Avalo Therapeutics Inc. Gross Profit — FAQ
Avalo Therapeutics Inc. (AVTX) gross profit over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVTX's gross profit history?
The chart and table above show Avalo Therapeutics Inc.'s gross profit by year and by quarter, including the growth rate.